|Bid||35.22 x 1100|
|Ask||35.17 x 3200|
|Day's range||34.80 - 35.47|
|52-week range||13.29 - 35.47|
|Beta (5Y monthly)||2.33|
|PE ratio (TTM)||N/A|
|Earnings date||27 Feb 2023 - 03 Mar 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||33.63|
(Bloomberg) -- CVS Health Corp. agreed to buy Oak Street Health Inc. in a $10.6 billion deal that further integrates primary care into the health-care conglomerate, positioning it to take advantage of a shift in how medical care is paid for.Most Read from BloombergMeta Asks Many Managers to Get Back to Making Things or LeaveGeorge Santos Gets Into Fight With Mitt Romney at State of the Union DebutBiden Taunts Xi Days After Shooting Down Chinese BalloonTrump Charges in Georgia Over 2020 Could Lea
Image source: The Motley Fool. CVS Health (NYSE: CVS)Q4 2022 Earnings CallFeb 08, 2023, 8:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorLadies and gentlemen, good morning and welcome to the CVS Health fourth quarter and full year 2022 earnings conference call.
Oak Street Health, Inc. (OSH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.